年別の研究成果
年別の研究成果
検索結果
-
2022
Recent advances in riboflavin transporter RFVT and its genetic disease
Jin, C. & Yonezawa, A., 2022 5月, In: Pharmacology and Therapeutics. 233, 108023.研究成果: Review article › 査読
14 被引用数 (Scopus) -
Therapeutic Drug Monitoring of Antibody Drugs
Yonezawa, A., 2022 7月, In: Biological and Pharmaceutical Bulletin. 45, 7, p. 843-846 4 p.研究成果: Review article › 査読
Open Access4 被引用数 (Scopus) -
2020
Current issues and future perspectives of biosimilar in cancer therapy
Yonezawa, A. & Matsubara, K., 2020 3月, In: Japanese Journal of Cancer and Chemotherapy. 47, 3, p. 397-401 5 p.研究成果: Review article › 査読
1 被引用数 (Scopus) -
2015
Boosting cancer immunotherapy with anti-CD137 antibody therapy
Yonezawa, A., Dutt, S., Chester, C., Kim, J. & Kohrt, H. E., 2015 7月 15, In: Clinical Cancer Research. 21, 14, p. 3113-3120 8 p.研究成果: Review article › 査読
Open Access109 被引用数 (Scopus) -
2013
Novel riboflavin transporter family RFVT/SLC52: Identification, nomenclature, functional characterization and genetic diseases of RFVT/SLC52
Yonezawa, A. & Inui, K. I., 2013 4月, In: Molecular Aspects of Medicine. 34, 2-3, p. 693-701 9 p.研究成果: Review article › 査読
124 被引用数 (Scopus) -
2011
Importance of the multidrug and toxin extrusion MATE/SLC47A family to pharmacokinetics, pharmacodynamics/toxicodynamics and pharmacogenomics
Yonezawa, A. & Inui, K. I., 2011 12月, In: British Journal of Pharmacology. 164, 7, p. 1817-1825 9 p.研究成果: Review article › 査読
Open Access162 被引用数 (Scopus)